Cette thèse décrit le développement et la méthodologie pour la synthèse de 2-pyrazolo[1,5-a]pyridines à partir d’ylures de N-iminopyridinium et d’halogénures de styryle. Des dérivés de chaque ylure de N-iminopyridinium et d’halogénures de styryle ont été utilisés pour la synthèse de plusieurs composés avec un intérêt pharmaceutique. Le premier chapitre présente les précédents littéraires pour la synthèse de pyrazolopyridines. Spécifiquement trois types différents de synthèse seront présentés en détail. L’importance biologique de ces composés sera discutée. La vue d’ensemble des travaux développés dans notre groupe de recherche pour la synthèse des produits de départ sera présentée brièvement. Finalement, la science intéressante qui a apporté cette idée de recherche sera révélée. Le deuxième chapitre décrit les résultats des optimisations étudiées pour la synthèse des 2-phénylpyrazolo[1,5-a]pyridines à partir d’ylures de N-benzoyl-iminopyridinium et d’iodure de styryle. Chaque substrat de la réaction a été étudié individuellement afin d’être optimisé; les ratios, les solvants, la température du milieu réactionnel et le temps optimal de la réaction ont aussi été explorés. Le troisième chapitre présente l’étendue de la synthèse des pyrazolopyridines. L’étendue de la réaction inclut les dérivés des halogénures de styryle. L’étendue de la réaction a été élargie aux dérivés d’ylures de N-iminopyridinium et ils incluent des groupements donneurs d’électrons ainsi que des groupements pauvres en électrons. Des groupements exotiques d’iodure et de bromure de vinyle ont aussi été explorés. Le quatrième chapitre démontre les études mécanistiques que l’on a faites pour mieux comprendre les cycles catalytiques qui ont lieu durant la réaction. Des études de cyclisation avec les ylures de N-iminopyridinium ont été explorées pour les produits de départ suivants : iodure de styryle et phényl acetylène. / This thesis describes the development of a methodology for the one-pot synthesis of 2-pyrazolo[1,5-a]pyridines from N-iminopyridinium ylide and styryl-halide starting materials. Both N-iminopyridinium ylide derivatives and styryl-halide derivatives were employed for the synthesis of various pharmaceutically interesting pyrazolo[1,5-a]pyridines. The first chapter presents the literature precedents for the synthesis of pyrazolopyridines. More specifically, three different types of syntheses will be shown in detail. Furthermore, the biological importance of these compounds will be discussed. An overview of the developed methodologies previously carried out in our research group for the synthesis of the starting materials will be presented. Finally, the copper-catalyzed direct alkenylation of N-iminopyridinium ylides that brought about this research idea will be discussed. The second chapter describes the results of the optimization studies for the synthesis of 2-phenyl pyrazolo[1,5-a]pyridines from N-benzoyliminopyridinium ylides and styryl iodides. Each component of the reaction was individually screened and the loading ratios were optimized: e.g., solvent and temperature. The third chapter presents the scope of the pyrazolopyridine synthesis. The scope includes styryl iodide, –bromide and –chloride derivatives. The scope of the reaction was extended to N-iminopyridinium ylide derivatives and included electron donating and electron withdrawing groups. Substituted vinyl iodides and bromides were also investigated. The fourth chapter demonstrates the mechanistic studies conducted in order to obtain an accurate understanding of the catalytic cycles taking place during the reaction. Cyclization studies were explored for both styryl iodides and phenyl acetylene starting materials reacted with N-iminopyridinium ylides.

<p>U radu je ostvarena sinteza četiri prirodna proizvoda, goniobutenolida A i B,<br />krasalaktona D i 3-deoksi-kardiobutanolida i 32 derivata i analoga polazeći iz<br />D-glukoze. Sinteza prirodnog stiril-laktona, kardiobutanolida&nbsp; i njegova 4<br />derivata je izvedena polazeći iz&nbsp; D-ksiloze.&nbsp; Ispitan je uticaj sintetizovanih<br />jedinjenja&nbsp; na inhibiciju rasta 10 tumorskih i jedne zdrave ćelijske linije.<br />Uspostavljene su i&nbsp; korelacije izmedju strukture i antiproliferativne aktivnosti&nbsp;(SAR) i ispitan je mehanzam antitumorskog dejstva.</p> / <p>Synthesis of four natural products: goniobutenolide A and B,&nbsp;crassalactone D, 3-deoxy-cardiobutanolide and their 32 analogues&nbsp;and derivatives is accomplished starting from&nbsp; D-glucose. Synthesis of natural styryl lactone cardiobutanolide and its four derivatives is &nbsp;achieved&nbsp; starting&nbsp; from&nbsp; D-xylose.&nbsp; Synthesized natural lactones, their analogues and derivatives were evaluated for their antiproliferative activity against ten malignant cell lines&nbsp; as well as against a single normal cell line. Influence of functional groups on antitumour activity was established by correlating structures of synthesized compounds&nbsp; with&nbsp; their&nbsp; biological&nbsp; activity (SAR).&nbsp; Also, mechanism of antitumour action was investigated.</p>

<p>U radu je ostvarena enantiodivergentna totalna sinteza oba enantiomera goniofufurona, 7-epi-goniofufurona i krasalaktona C polazeći iz D-glukoze. Ključne faze u sintezi 7-epi-(+)-goniofufurona bile su stereoselektivna adicija fenilmagnezijum bromida na aldehidnu grupu pogodno za&scaron;tićene dialdoze, i stereospecifično formiranje furano-laktonskog prstena ciklokondenzacijom odabranog hemiacetalnog derivata sa Meldrum-ovom kiselinom. Sinteza (+)-goniofufurona i (+)-krasalaktona C zahtevala je inverziju konfiguracije na C-5<br />u zajedničkom intermedijeru, koja je efikasno ostvarena u uslovima Mitsunobu-ove reakcije, ili alternativno oksidacijom benzilne hidroksilne grupe u prohiralni keton, uz naknadnu stereoselektivnu redukcijom sa borohidridom. Sličan pristup je zatim primenjen za sintezu neprirodnih (&minus;)-enantiomera goniofufurona, 7-epi-goniofufurona i krasalaktona C, dva nova konformaciono ograničena analoga (+)- i (&minus;)-goniofufurona (oksetani 36 i ent-36), kao i odgovarajućih 7-deoksigenovanih derivata (31 i ent-31). Takodje je razvijena i prva totalna sinteza prirodnog (+)-krasalaktona B (3) i alternativna sinteza (+)-krasalaktona C (4) polazeći iz D-glukoze. Selektivni pristup molekulima 3, odnosno 4 omogućen je promenom uslova za TBDPS deprotekciju u finalnom intermedijeru 53. Osnovna karakteristika pomenutih pristupa je njihova generalnost i fleksibilnost. Na taj način je omogućena sinteza serije analoga i derivata (+)-goniofufurona, ili 7-epi-goniofufurona, uključujući i do sada nepoznate 7-epi-(+)-krasalaktone B (6) i C (7), 5,7-di-O-cinamoil derivate 8 i 9, 5,7-di-O-izopropilidenske derivate 5 i 10, kao i vi&scaron;e lipofilnih derivata (jedinjenja 26, 30, 33, 65, ent-30 i ent-33). Konačno, u drugom delu rada, ispitan je uticaj sintetizovanih stiril-laktona na rast odabranih tumorskih ćelijskih linija in vitro.</p> / <p> Enantiodivergent total syntheses of both (+)- and (&minus;)-enantiomers of goniofufurone, 7-epi-goniofufurone and crassalactone C have been accomplished starting from D-glucose. The key steps of the synthe-sis of 7-epi-(+)-goniofufurone were a stereo-selective addition of&nbsp;<br /> phenyl magnesium bromide to a protected dialdose, followed by a stereospecific furano-lactone ring formation by condensation of a partially protected lactole with Meldrum&rsquo;s acid. The synthesis of (+)-goniofufurone and (+)-crassalactone C required a configurational inversion at C-5 in the common intermediate that was efficiently achieved under the standard Mitsunobu conditions, or alternatively through a sequential oxidation of the benzylic hydroxyl group followed by a stereo-selective reduction with borohydride. A similar approach was applied to the synthesis of the unnatural enantiomers of goniofufurone, 7-epi-goniofufurone and crassalactone C, two novel, conformationally constrained analogues of both (+)- and (&minus;)-goniofufurone (oxetanes 34 and ent-34). as well as the corresponding 7-deoxygenated derivatives (31 and ent-31). We have also developed the first total synthesis of (+)-crassalactone B (2) and an alternative synthesis of (+)-crassalactone C (3) starting from D-glucose. Finally, the synthesized styryl-lactones were evaluated for their antiproliferative activity against a panel of human tumor cell lines.</p>